ORAL D has a total of 13 patent applications. Its first patent ever was published in 1984. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are SHANGHAI HUAJIN BIOTECHNOLOGY CO LTD, Shanxi Tumour Hospital and FILECO SA.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 2 | |
#3 | Australia | 1 | |
#4 | Canada | 1 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | Israel | 1 | |
#7 | Italy | 1 | |
#8 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Green Donald E | 12 |
Publication | Filing date | Title |
---|---|---|
US5550161A | Substituted orally effective ION chelators related to deferoxamine | |
WO9220227A1 | Substituted orally effective ion chelators related to deferoxamine | |
US5047421A | Orally effective ion chelators | |
US5015664A | Orally effective ion chelators related to deferoxamine | |
US4671901A | Orally effective ion chelators | |
US4684482A | Orally effective ion chelators |